Clinical Trial Update: NM32-2668 in Adult Patients With Selected Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial of NM32-2668 in adults with selected advanced solid tumors has been terminated. The study enrolled multiple tumor types including ovarian carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Endometrial Cancer
• Fallopian Tube Carcinoma
• Malignant Mesothelioma
• Ovarian Carcinoma
• Peritoneal Carcinoma
• Renal Cell Carcinoma
• Triple-negative Breast Cancer

Drugs mentioned

• NM32-2668

Snippet

Sponsor: Numab Therapeutics AG | Conditions: Ovarian Carcinoma, Fallopian Tube Carcinoma | Phase 1 | Status: TERMINATED